IBL HealthCare Limited (PSX:IBLHL)
Pakistan
· Delayed Price · Currency is PKR 37.13
0.00 (0.00%)
At close: Apr 3, 2025
IBL HealthCare Income Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Revenue | 3,721 | 3,603 | 4,028 | 3,651 | 3,004 | 2,665 | Upgrade
|
| Revenue Growth (YoY) | -8.81% | -10.54% | 10.32% | 21.55% | 12.73% | 68.12% | Upgrade
|
| Cost of Revenue | 2,785 | 2,654 | 2,691 | 2,400 | 1,985 | 1,857 | Upgrade
|
| Gross Profit | 936.46 | 949.32 | 1,336 | 1,251 | 1,019 | 807.59 | Upgrade
|
| Selling, General & Admin | 767.38 | 795.96 | 726.7 | 680.77 | 606.06 | 508.47 | Upgrade
|
| Other Operating Expenses | 17.62 | - | - | - | - | - | Upgrade
|
| Operating Expenses | 785.01 | 795.96 | 726.7 | 680.77 | 612.19 | 508.47 | Upgrade
|
| Operating Income | 151.45 | 153.35 | 609.68 | 570.69 | 406.77 | 299.12 | Upgrade
|
| Interest Expense | -60.18 | -65.43 | -64.14 | -25.7 | -26.34 | -29.93 | Upgrade
|
| Interest & Investment Income | - | - | - | - | 10.47 | 30.57 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.52 | 27.18 | -109.57 | -72.83 | 3.87 | 1.11 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.6 | 3.7 | 22.86 | 9.81 | 13.09 | 20.93 | Upgrade
|
| EBT Excluding Unusual Items | 95.39 | 118.8 | 458.82 | 481.97 | 407.87 | 321.81 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.01 | 1.92 | - | - | Upgrade
|
| Asset Writedown | -10.1 | -10.1 | - | -0.62 | - | - | Upgrade
|
| Pretax Income | 85.29 | 108.7 | 458.83 | 483.27 | 409.15 | 321.81 | Upgrade
|
| Income Tax Expense | 108.74 | 101.15 | 149.87 | 180.41 | 108.66 | 101.78 | Upgrade
|
| Net Income | -23.45 | 7.56 | 308.96 | 302.86 | 300.49 | 220.03 | Upgrade
|
| Net Income to Common | -23.45 | 7.56 | 308.96 | 302.86 | 300.49 | 220.03 | Upgrade
|
| Net Income Growth | - | -97.56% | 2.02% | 0.79% | 36.57% | 81.28% | Upgrade
|
| Shares Outstanding (Basic) | 86 | 86 | 86 | 86 | 86 | 86 | Upgrade
|
| Shares Outstanding (Diluted) | 86 | 86 | 86 | 86 | 86 | 86 | Upgrade
|
| Shares Change (YoY) | - | - | - | 0.00% | -0.00% | - | Upgrade
|
| EPS (Basic) | -0.27 | 0.09 | 3.61 | 3.53 | 3.51 | 2.57 | Upgrade
|
| EPS (Diluted) | -0.27 | 0.09 | 3.61 | 3.53 | 3.51 | 2.57 | Upgrade
|
| EPS Growth | - | -97.56% | 2.02% | 0.79% | 36.57% | 81.28% | Upgrade
|
| Free Cash Flow | -63.85 | 566.44 | 24.34 | 55.56 | 65.09 | 36.37 | Upgrade
|
| Free Cash Flow Per Share | -0.74 | 6.61 | 0.28 | 0.65 | 0.76 | 0.42 | Upgrade
|
| Dividend Per Share | - | - | - | 0.757 | 0.631 | 1.263 | Upgrade
|
| Dividend Growth | - | - | - | 19.99% | -50.00% | 100.00% | Upgrade
|
| Gross Margin | 25.16% | 26.35% | 33.18% | 34.28% | 33.92% | 30.31% | Upgrade
|
| Operating Margin | 4.07% | 4.26% | 15.14% | 15.63% | 13.54% | 11.23% | Upgrade
|
| Profit Margin | -0.63% | 0.21% | 7.67% | 8.29% | 10.00% | 8.26% | Upgrade
|
| Free Cash Flow Margin | -1.72% | 15.72% | 0.60% | 1.52% | 2.17% | 1.36% | Upgrade
|
| EBITDA | 153.65 | 156.44 | 612.95 | 575.98 | 411.77 | 303.41 | Upgrade
|
| EBITDA Margin | 4.13% | 4.34% | 15.22% | 15.78% | 13.71% | 11.39% | Upgrade
|
| D&A For EBITDA | 2.2 | 3.09 | 3.28 | 5.29 | 5 | 4.29 | Upgrade
|
| EBIT | 151.45 | 153.35 | 609.68 | 570.69 | 406.77 | 299.12 | Upgrade
|
| EBIT Margin | 4.07% | 4.26% | 15.14% | 15.63% | 13.54% | 11.23% | Upgrade
|
| Effective Tax Rate | 127.49% | 93.05% | 32.66% | 37.33% | 26.56% | 31.63% | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.